November 2019
Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, is currently conducting more than 120 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches.
New probody immuno-oncology study for
solid tumors
Probody therapeutics are an emerging class of immuno-oncology therapies aimed at reducing the immune-related side effects associated with immune checkpoint inhibitors. A new multicohort study at Providence Cancer Institute tests the anticancer effects of an experimental probody therapeutic in patients with solid cancers:

All current open studies:
Find additional studies for many types of cancer in Multiple Tumor Types .
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.